{
    "Trade/Device Name(s)": [
        "Thyretain TSI Reporter BioAssay",
        "TSI Reporter"
    ],
    "Submitter Information": "Diagnostic Hybrids, Inc.",
    "510(k) Number": "K083391",
    "Predicate Device Reference 510(k) Number(s)": [
        "K032134"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "JZO"
    ],
    "Summary Letter Date": "May 21, 2009",
    "Summary Letter Received Date": "May 8, 2009",
    "Submission Date": "November 14, 2008",
    "Regulation Number(s)": [
        "21CFR866.5870"
    ],
    "Regulation Name(s)": [
        "Thyroid autoantibody immunological test system"
    ],
    "Analyte Class(es)": [
        "autoimmune",
        "immunology",
        "endocrine"
    ],
    "Analyte(s)": [
        "Thyroid stimulating autoantibodies to TSH receptor (TSI)"
    ],
    "Specimen Type(s)": [
        "Serum"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "Luminometer",
        "CHO Mc4 cell line in 96-well microplate"
    ],
    "Method(s)/Technology(ies)": [
        "Cell-based chemiluminescent assay",
        "Luciferase reporter assay"
    ],
    "Methodologies": [
        "Bioassay",
        "Chemiluminescent immunoassay"
    ],
    "Submission Type(s)": [
        "Assay",
        "Kit",
        "Reagent",
        "Control",
        "Panel"
    ],
    "Document Summary": "FDA 510(k) summary for Thyretain TSI Reporter BioAssay for qualitative detection of thyroid stimulating autoantibodies (TSI) in serum using a cell-based luciferase reporter assay for differential diagnosis of Graves' disease.",
    "Indications for Use Summary": "Qualitative detection in serum of thyroid stimulating autoantibodies to TSH receptors; detection aids differential diagnosis of Graves' disease in conjunction with other clinical and laboratory findings.",
    "fda_folder": "Immunology"
}